Glenmark USA Settles Antitrust Lawsuits for $15.28M

Glenmark Pharmaceuticals Ltd. announced that its subsidiary, Glenmark Pharmaceuticals Inc., USA, has entered into a settlement agreement with Humana, Inc. for $15.28 million to resolve antitrust and consumer protection lawsuits. These lawsuits, consolidated in the Eastern District of Pennsylvania, alleged price-fixing and anti-competitive conduct related to generic pharmaceutical products. Glenmark USA denies all allegations, and the settlement does not constitute an admission of liability. The full settlement amount has been provided for in the company's financials and is not expected to have a significant impact on the company's financial position.